American Diabetes Association Endorses New Aspirin Guidelines for Diabetic Patients
Women under 60 and men under 50 who have diabetes but no other major risk factors for heart disease probably should not be on low-dose aspirin therapy, new research suggests.
The new recommendations are based on close examination of nine studies that found the risks of some aspirin side effects, such as stomach bleeding, should be better balanced against the possible benefits of using aspirin.
The new guidelines suggest low-dose aspirin therapy be used by men over 50 and women over 60 with diabetes who have other risk factors for heart attack and stroke.
Diabetic men younger than 50 and diabetic women younger than 60 who have no other risk factors should probably not use low-dose aspirin as a heart attack preventative, according to new guidance from medical experts.
A panel endorsed by the American Diabetes Association, the American Heart Association and the American College of Cardiology Foundation published the revised recommendations in the journal Diabetes Care.
Diabetics are at two to four times increased risk for heart problems compared with people without diabetes. Many doctors advise their diabetic patients to take daily low-dose aspirin to fight the risk for heart problems. But the revised recommendations urge more conservative use of low-dose aspirin, especially for younger diabetics. The U.S. Preventive Services Task Force is still recommending aspirin use for older adults who are not diabetics – ages 45-79 for men, 55-79 for women – and who have other risk factors.
As per the latest findings of a study that has been published online in the journal Diabetes Care, young diabetics should keep aspirin at bay.
Experts are recommending that the low-dose aspirin therapy, which is primarily used in the prevention of heart attacks, should be avoided, particularly by young diabetic patients.
The recommendation of the study highlights that men younger than 50 and women younger than 60 should avoid using aspirin.
A new report has recommended that adults with diabetes who are at increased risk of cardiovascular disease and not at increased risk for bleeding should take low doses of aspirin to help prevent heart disease . It found that low-dose aspirin therapy was useful for most men over 50 and women over 60 with diabetes who have one or more additional heart disease risk factors.
However, those under those ages in each group are not recommended to take aspirin, as the potential adverse effects from gastrointestinal bleeding offset the potential benefits of treatment.